Case number 2:17-cv-00343
Allergan Sales, LLC et al v. Teva Pharmaceuticals USA, Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2020 | 9 | Order (1) |
| Sep 22, 2020 | 15 | Motion for Extension of Time to File Answer (2) |
| Sep 22, 2020 | 15 | Text of Proposed Order (1) |
| Sep 22, 2020 | N/A | Remark (0) |
| Sep 22, 2020 | 16 | Order (2) |
| Nov 21, 2017 | 17 | Notice of Appeal - FEDERAL CIRCUIT (3) |
| Nov 21, 2017 | 17 | Notice of Appeal* (1) |
| Jul 4, 2017 | N/A | Notice of Magistrate Availability (0) |
| Jul 3, 2017 | 13 | Answer to Complaint (33) |
| Jul 3, 2017 | 13 | Exhibit A - Label (16) |
| Jul 3, 2017 | 14 | Corporate Disclosure Statement (3) |
| Jun 30, 2017 | 10 | Notice of Attorney Appearance - Pro Hac Vice (2) |
| Jun 30, 2017 | 11 | Notice of Attorney Appearance - Pro Hac Vice (2) |
| Jun 30, 2017 | 12 | Notice of Attorney Appearance - Pro Hac Vice (2) |
| Apr 21, 2017 | N/A | Notice of Magistrate Availability (0) |
| Apr 21, 2017 | 1 | Complaint (10) |
| Apr 21, 2017 | 1 | Civil Cover Sheet (1) |
| Apr 21, 2017 | 1 | Exhibit A (17) |
| Apr 21, 2017 | 1 | Exhibit B (5) |
| Apr 21, 2017 | 2 | Notice of Filing of Patent/Trademark Form (AO 120) (1) |
| Apr 21, 2017 | 3 | Notice of Attorney Appearance (2) |
| Apr 21, 2017 | 4 | Notice of Attorney Appearance (2) |
| Apr 21, 2017 | 5 | Corporate Disclosure Statement (2) |
| Apr 21, 2017 | 6 | Corporate Disclosure Statement (2) |
| Apr 21, 2017 | 7 | Case Assigned/Reassigned (2) |
| Apr 21, 2017 | 8 | Summons Issued (2) |
| Apr 21, 2017 | 1 | Complaint* (1) |
